Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs

Background: The use of mesenchymal stem cells (MSCs) for the development of tissue-engineered constructs has advanced in recent years. However, future clinically approved products require following good manufacturing practice (GMP) guidelines. This includes using alternatives to xenogeneic-derived c...

Full description

Bibliographic Details
Main Authors: Luis Oliveros Anerillas, Mikael Wiberg, Paul J. Kingham, Peyman Kelk
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Regenerative Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352320423000755
_version_ 1797448077743751168
author Luis Oliveros Anerillas
Mikael Wiberg
Paul J. Kingham
Peyman Kelk
author_facet Luis Oliveros Anerillas
Mikael Wiberg
Paul J. Kingham
Peyman Kelk
author_sort Luis Oliveros Anerillas
collection DOAJ
description Background: The use of mesenchymal stem cells (MSCs) for the development of tissue-engineered constructs has advanced in recent years. However, future clinically approved products require following good manufacturing practice (GMP) guidelines. This includes using alternatives to xenogeneic-derived cell culture supplements to avoid rejection of the transplants. Consequently, human platelet lysate (PLT) has been adopted as an affordable and effective alternative to foetal bovine serum (FBS) in traditional 2D cultures. However, little is known about its effect in more advanced 3D culture systems. Methods: We evaluated bone marrow MSCs (BMSCs) proliferation and CD marker expression in cells expanded in FBS or PLT-supplemented media. Differentiation capacity of the BMSCs expanded in the presence of the different supplements was evaluated in 3D type I collagen hydrogels. Furthermore, the effects of the supplements on the process of differentiation were analyzed by using qPCR and histological staining. Results: Cell proliferation was greater in PLT-supplemented media versus FBS. BMSCs expanded in PLT showed similar osteogenic differentiation capacity in 3D compared with FBS expanded cells. In contrast, when cells were 3D differentiated in PLT they showed lower osteogenesis versus the traditional FBS protocol. This was also the case for adipogenic differentiation, in which FBS supplementation was superior to PLT. Conclusions: PLT is a superior alternative to FBS for the expansion of MSCs without compromising their subsequent differentiation capacity in 3D. However, differentiation in PLT is impaired. Thus, PLT can be used to reduce the time required to expand the necessary cell numbers for development of 3D tissue engineered MSC constructs.
first_indexed 2024-03-09T14:05:10Z
format Article
id doaj.art-cac198d770fd4a729c1e2776e6f67c72
institution Directory Open Access Journal
issn 2352-3204
language English
last_indexed 2024-03-09T14:05:10Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Regenerative Therapy
spelling doaj.art-cac198d770fd4a729c1e2776e6f67c722023-11-30T05:07:49ZengElsevierRegenerative Therapy2352-32042023-12-0124298310Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructsLuis Oliveros Anerillas0Mikael Wiberg1Paul J. Kingham2Peyman Kelk3Department of Integrative Medical Biology, Umeå University, 901 87 Umeå, Sweden; Corresponding author.Department of Integrative Medical Biology, Umeå University, 901 87 Umeå, Sweden; Department of Surgical & Perioperative Sciences, Section for Hand and Plastic Surgery, Umeå University, 901 87 Umeå, SwedenDepartment of Integrative Medical Biology, Umeå University, 901 87 Umeå, SwedenDepartment of Integrative Medical Biology, Umeå University, 901 87 Umeå, Sweden; Corresponding author.Background: The use of mesenchymal stem cells (MSCs) for the development of tissue-engineered constructs has advanced in recent years. However, future clinically approved products require following good manufacturing practice (GMP) guidelines. This includes using alternatives to xenogeneic-derived cell culture supplements to avoid rejection of the transplants. Consequently, human platelet lysate (PLT) has been adopted as an affordable and effective alternative to foetal bovine serum (FBS) in traditional 2D cultures. However, little is known about its effect in more advanced 3D culture systems. Methods: We evaluated bone marrow MSCs (BMSCs) proliferation and CD marker expression in cells expanded in FBS or PLT-supplemented media. Differentiation capacity of the BMSCs expanded in the presence of the different supplements was evaluated in 3D type I collagen hydrogels. Furthermore, the effects of the supplements on the process of differentiation were analyzed by using qPCR and histological staining. Results: Cell proliferation was greater in PLT-supplemented media versus FBS. BMSCs expanded in PLT showed similar osteogenic differentiation capacity in 3D compared with FBS expanded cells. In contrast, when cells were 3D differentiated in PLT they showed lower osteogenesis versus the traditional FBS protocol. This was also the case for adipogenic differentiation, in which FBS supplementation was superior to PLT. Conclusions: PLT is a superior alternative to FBS for the expansion of MSCs without compromising their subsequent differentiation capacity in 3D. However, differentiation in PLT is impaired. Thus, PLT can be used to reduce the time required to expand the necessary cell numbers for development of 3D tissue engineered MSC constructs.http://www.sciencedirect.com/science/article/pii/S2352320423000755Foetal bovine serumHuman platelet lysateMesenchymal stem cellsOsteogenesis3D
spellingShingle Luis Oliveros Anerillas
Mikael Wiberg
Paul J. Kingham
Peyman Kelk
Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs
Regenerative Therapy
Foetal bovine serum
Human platelet lysate
Mesenchymal stem cells
Osteogenesis
3D
title Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs
title_full Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs
title_fullStr Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs
title_full_unstemmed Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs
title_short Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs
title_sort platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3d tissue constructs
topic Foetal bovine serum
Human platelet lysate
Mesenchymal stem cells
Osteogenesis
3D
url http://www.sciencedirect.com/science/article/pii/S2352320423000755
work_keys_str_mv AT luisoliverosanerillas plateletlysateforexpansionorosteogenicdifferentiationofbonemarrowmesenchymalstemcellsfor3dtissueconstructs
AT mikaelwiberg plateletlysateforexpansionorosteogenicdifferentiationofbonemarrowmesenchymalstemcellsfor3dtissueconstructs
AT pauljkingham plateletlysateforexpansionorosteogenicdifferentiationofbonemarrowmesenchymalstemcellsfor3dtissueconstructs
AT peymankelk plateletlysateforexpansionorosteogenicdifferentiationofbonemarrowmesenchymalstemcellsfor3dtissueconstructs